Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Donation for new Center for Pharmaceutical Nanotechnology and Nanotoxicology

Abstract:
Prof. Moein Moghimi (Professor of Biopharmacy and Nanomedicine, Department of Pharmaceutics and Analytical chemistry) and colleagues have received 28 million DKK (approximately 3.75 million Euros) from the Danish Council for Strategic Research (DSF) to set The Centre for Pharmaceutical Nanotechnology and Nanotoxicology (CPNN) at the Faculty of Pharmaceutical Sciences starting April 2009.

Donation for new Center for Pharmaceutical Nanotechnology and Nanotoxicology

Copenhagen, Denmark | Posted on December 24th, 2008

Prof. Moghimi will act as the Director of the Centre and Prof. Thomas Bjørnholm (Head of the NanoScience Centre) will be the Chairman of the Steering Committee.

The development of a wide spectrum of promising nanoscale materials, either in their own right or as a component of multifunctional platforms, is beginning to have a paradigm-shifting impact in medicine; they are changing the foundations of disease diagnosis, monitoring and treatment, and turning molecular discoveries into benefits for patients. Research into delivery and targeting of pharmaceutical, therapeutic, and diagnostic agents via intravenous and interstitial routes of administration with particulate drug carriers and nanoconstructs is at the forefront of projects in nanomedicine, but the biological performance of such delivery systems still requires optimization.

The principal investigator Prof. Moghimi said "the future of particulate and polymeric nanomedicines will depend on rational design of nanotechnology materials and tools based around a detailed and thorough molecular understanding of biological processes, rather than forcing applications for some materials currently in vogue". Therefore, the prime research focus of the Centre is to unravel the molecular basis of nanomaterial performance and toxicity through "structure-activity" assessments at membrane organelle, cellular and animal level in combination with and by improving/optimizing the performance of the state-of-the-art bio-nanotechnology techniques. This integrated and multidisciplinary approach is expected to improve therapeutic benefit-to-risk ratio.

CPNN also intend to provide "bench-mark protocols" for toxicity evaluation of nanomedicines in animals, and at cellular and molecular levels, as the sensitivity and precision of the standard toxicological procedures are of arguable value in nanomedicine research and development as it is limited to spotting extreme toxicity.

CPNN also receives substantial in-kind contribution (at present in the region of 10 million DKK) from pharmaceutical and biotechnology industry. The Centre has a critical mass of academic and industrial expertise and necessary tools to conduct the task, thus reinforcing competitiveness at international level. Partners include NanoScience Centre at the University of Copenhagen (Prof. Bjørnholm and Associate Prof. D. Stamou), Faculty of Health Sciences at University of Copenhagen (Prof. S. Loft), DTU-Nanotech (Senior Scientist T. Andresen), Lundbeck A/S, LiPlasome A/S and Nordic Vaccine A/S. The international dimension of CPNN is further reflected through collaborations with centres of excellence world-wide including USA, Switzerland, EU as well as the growth countries China and Hungary.

Prof. Moghimi also said "our success would help the transformation of National and European biotechnology and pharmaceutical industries towards a knowledge-intensive, globally competitive one. In addition, the safe use of nanoparticulate delivery systems will also give Denmark and EU significant savings in pharmaceutical spending, which continue to grow".

Training of at least 9 PhD students and 5-6 post doctoral scientists are envisaged at the highest level gaining maximum benefit through close collaboration with industrial partners and international network as well as by the training offered through the Graduate Schools of Drug Discovery (Faculty of Pharmaceutical Sciences) and Nanotechnology (Nano-Science Center).

####

For more information, please click here

Contacts:
Professor Seyed Moein Moghimi

453-533-6528

Copyright © University of Copenhagen

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Measuring the Smallest Magnets July 28th, 2014

WITec to host the 11th Confocal Raman Imaging Symposium from September 29th - October 1st in Ulm, Germany July 28th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

Production of Toxic Gas Sensor Based on Nanorods July 28th, 2014

Academic/Education

Haydale Announces Collaboration Agreement with Swansea University’s Welsh Centre for Printing and Coatings (WCPC) July 12th, 2014

STFC takes delivery of the 100th Hitachi Tabletop SEM in the UK July 3rd, 2014

Innovation Management and the Emergence of the Nanobiotechnology Industry July 1st, 2014

Albany NanoCollege Faculty Member Selected as Editor-in-Chief of the Prestigious Journal of Electronic Materials July 1st, 2014

Nanomedicine

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

New imaging agent provides better picture of the gut July 25th, 2014

Scientists Test Nanoparticle "Alarm Clock" to Awaken Immune Systems Put to Sleep by Cancer July 25th, 2014

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

Announcements

Measuring the Smallest Magnets July 28th, 2014

WITec to host the 11th Confocal Raman Imaging Symposium from September 29th - October 1st in Ulm, Germany July 28th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

Production of Toxic Gas Sensor Based on Nanorods July 28th, 2014

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

New imaging agent provides better picture of the gut July 25th, 2014

Hysitron is Awarded TWO R&D 100 Awards for Highly Innovative Technology Developments in the Areas of Extreme Environments and Biological Mechanical Property Testing July 23rd, 2014

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

EPFL Research on the use of AFM based nanoscale IR spectroscopy for the study of single amyloid molecules wins poster competition at Swiss Physics Society meeting July 22nd, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE